Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Appointment of Blair McInnis as CFO

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
March 16, 2022 08:00 ET | Source: Spectral Medical Inc.

Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device

TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly owned subsidiary, Dialco Medical Inc. (“Dialco”), has...
March 04, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical CMO Dr. John Kellum to Present at the 27th International AKI & CRRT Conference on March 7-10, 2022

TORONTO, March 04, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
February 11, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Reports Progress on Tigris Clinical Trial

Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased patient enrollment TORONTO, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Spectral Medical...
January 31, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment

TORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has...
December 03, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that Chris...
November 30, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Schedules Conference Call to Provide Clinical Update and Discuss Latest Developments

TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that it will...
November 29, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria

Amendment aligns eligibility for Tigris with current clinical practice in septic shock Potential to improve Tigris enrollment rates by 25% to 50% and reduce time to trial completion Five additional...
November 12, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Announces Third Quarter Results and Provides Corporate Update

TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
October 25, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral to Present at the Benzinga Global Small Cap Conference on October 27, 2021

TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that Chris...